| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/13/2006 | US20060079511 7,8-Disubstituted pyrazolobenzodiazepines |
| 04/13/2006 | US20060079510 Use of PARP-1 inhibitors for protecting tumorcidal lymphocytes from apoptosis |
| 04/13/2006 | US20060079509 Antineoplastic agents; inhibitors of cancer cell growth, mammalian lipoxygenase, acute and chronic inflammation |
| 04/13/2006 | US20060079508 10-farnesyl-4,6,8-trihydroxy-dibenzodiazepin-11-one; ECO-4601; anticarcinogenic, antitumor agent; early stage of cancer; reducing side-effects on normal cells |
| 04/13/2006 | US20060079507 Substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/13/2006 | US20060079505 Modulators of muscarinic receptors |
| 04/13/2006 | US20060079504 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 04/13/2006 | US20060079503 Thiazolidinones and the use therof as polo-like kinase inhibitors |
| 04/13/2006 | US20060079502 Pharmaceutical compositions |
| 04/13/2006 | US20060079501 Compositions of an anticonvulsant and mirtazapine to prevent weight gain |
| 04/13/2006 | US20060079500 Medicament and method for reducing alcohol and/or tobacco consumption |
| 04/13/2006 | US20060079499 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 04/13/2006 | US20060079498 ((2S,4S)-4-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)pyrrolidin-2-yl)-(3,3-difluoropyrrolidin-1-yl)-methanone dihydrochloride; dipeptidyl peptidase-IV inhibitor; diabetic complications including diabetic neuropathy, diabetic nephropathy, diabetic microangiopathy |
| 04/13/2006 | US20060079497 Lavendamycin analogues and methods of synthesizing and using lavendamycin analogues |
| 04/13/2006 | US20060079496 Agglomerates by crystallisation |
| 04/13/2006 | US20060079495 Diagnosis and treatment system for "reward deficiency syndrome" (RDS) and related behaviors |
| 04/13/2006 | US20060079494 Specific kinase inhibitors |
| 04/13/2006 | US20060079493 Such as rheumatoid arthritis or cancer, with HSP90 inhibitor such as 17-allylaminogeldanamycin (17-AAG), geldanamycin, herbimycin A, and macbecin; pharmacogenetics |
| 04/13/2006 | US20060079492 Compositions and treatment methods |
| 04/13/2006 | US20060079491 Method of female hormonal contraception using a fixed extended cycle hormonal preparation containing dienogest and ethinyl estradiol |
| 04/13/2006 | US20060079490 Method of treatment of type I diabetes |
| 04/13/2006 | US20060079489 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 04/13/2006 | US20060079488 Methods of treating and preventing bone loss |
| 04/13/2006 | US20060079487 including pyridinium-1-yl, quinolinium-1-yl, and related compounds; parasitic infections, for example against trypanosomes; inhibiting the enzyme farnesyl diphosphate synthase |
| 04/13/2006 | US20060079486 Lipopolymer conjugates |
| 04/13/2006 | US20060079485 administering complex of phospholipid and drug |
| 04/13/2006 | US20060079484 Antithrombotic effect |
| 04/13/2006 | US20060079483 Low molecular weight heparins that are substantially pure and have homogeneous structural configurations, confirmations, and stereomeric compositions; buffered saline solutions; substituted 6,8-dioxabicyclo(3.2.1)octane or furo[2,3-D]-1,3-dioxole synthetic precursors |
| 04/13/2006 | US20060079482 Ophthalmic compositions including lubricant, deturgescent agent, and glycosaminoglycan and methods of using the same |
| 04/13/2006 | US20060079481 Method of treating/preventing mucositis |
| 04/13/2006 | US20060079480 Novel antifolate combination therapies |
| 04/13/2006 | US20060079479 Methods of inducing vasodilation |
| 04/13/2006 | US20060079478 improved pharmacokinetic properties; oral bioavailibility; less side effects; novel intermediates; novel methods for synthesis; help to diagnose cancer/leukemia in vitro; inhibitors of adenosine deaminase |
| 04/13/2006 | US20060079470 Combined dna vaccine and biological modifiers for cancer therapy |
| 04/13/2006 | US20060079469 Anti-restenosis agent |
| 04/13/2006 | US20060079468 7-(2'-C-methyl- beta -D-ribofuranosyl)-4-amino-5-(ethen-1-yl)- or -[(ethyl 2-carboxyl)ethyn-1-yl]-pyrrolo[2,3-d]pyrimidine; treating hepatitis C |
| 04/13/2006 | US20060079467 administering plants extracts which inhibits cyclooxygenases and lipoxygenases, and reduces cytokine production; periodontal diseases |
| 04/13/2006 | US20060079466 Rapamycin carbohydrate derivatives |
| 04/13/2006 | US20060079465 isolated from the Caenorhabditis elegance related to suppress of aging and stress |
| 04/13/2006 | US20060079464 Peritoneal dialysate containing taurine |
| 04/13/2006 | US20060079463 Anticancer compositions comprising methenamine |
| 04/13/2006 | US20060079462 Organoselenium compounds for cancer chemoprevention |
| 04/13/2006 | US20060079461 Treatment of multiple myeloma by inhibition of p38 MAP kinase |
| 04/13/2006 | US20060079460 Purified LH |
| 04/13/2006 | US20060079458 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 04/13/2006 | US20060079452 Administering anakinra |
| 04/13/2006 | US20060079451 Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same |
| 04/13/2006 | US20060079450 Polypeptide that does not include an N-linked glycosylation site such as interleukin-11 stabilized with hydroxyethyl starch and a disaccharide such as trehalose and sucrose; stable for at least 9 months when stored at 60 degrees C. |
| 04/13/2006 | US20060079448 Compounds and methods for increasing neurogenesis |
| 04/13/2006 | US20060079447 Stabilized A-beta protofibrillar aggregates |
| 04/13/2006 | US20060079442 Methods and uses of leptin in immune modulation and hepatocellular carcinoma |
| 04/13/2006 | US20060079439 Elastin prevents occlusion of body vessels by vascular smooth muscle cells |
| 04/13/2006 | US20060079314 System and method for facilitating play of a game with user-selected elements |
| 04/13/2006 | US20060078980 Production of polyketides and other natural products |
| 04/13/2006 | US20060078975 Crystal structure of enzyme and uses thereof |
| 04/13/2006 | US20060078971 Isoflavone-beta-D-glucan produced by Agaricus blazei in the submerged liquid culture and method of producing same |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078874 Use of nuclear hormone receptors |
| 04/13/2006 | US20060078632 Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease |
| 04/13/2006 | US20060078630 Method for the production of flavonoid-containing compositions and use thereof |
| 04/13/2006 | US20060078629 Nutritional compositions and use thereof |
| 04/13/2006 | US20060078627 Composition for treatment of obesity or generally aiding weight loss in pill, powder or liquid form, by appetite reduction and metabolism increase, comprising: L- phenylalanine, caffeine, and one or more of the group of all forms of 5-hydroxytryptophan and L-tryptophan, all from either natural or synthetic sources |
| 04/13/2006 | US20060078626 Opthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 04/13/2006 | US20060078625 Compositions including krill extracts and conjugated linoleic acid and methods of using same |
| 04/13/2006 | US20060078620 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia |
| 04/13/2006 | US20060078619 Method for the preparatin of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared thereby |
| 04/13/2006 | US20060078617 Pharmaceutical compositions for the treatment of cancer |
| 04/13/2006 | US20060078616 Thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol |
| 04/13/2006 | US20060078613 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy |
| 04/13/2006 | US20060078609 Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water soluble and respectively base |
| 04/13/2006 | US20060078607 Liposome formulation of 6,9-bis[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate |
| 04/13/2006 | US20060078606 Sustained-release liposomal anesthetic compositions |
| 04/13/2006 | US20060078605 Pharmaceutical composition of small-sized liposomes and method of preparation |
| 04/13/2006 | US20060078600 Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof |
| 04/13/2006 | US20060078599 Pharmaceutical composition applicable to body tissue |
| 04/13/2006 | US20060078597 Ascorbic acid salt suspensions and use thereof as antioxidants |
| 04/13/2006 | US20060078596 Treatment of muscle fatigue |
| 04/13/2006 | US20060078595 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 04/13/2006 | US20060078594 Iron complex |
| 04/13/2006 | US20060078589 Device for treating oral wound gaps |
| 04/13/2006 | US20060078583 Device for delivering an anti-microbial composition |
| 04/13/2006 | US20060078582 Use of compositions for treating rosacea |
| 04/13/2006 | US20060078575 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 04/13/2006 | US20060078568 Use of the residues from wine production |
| 04/13/2006 | US20060078560 Method of inducing apoptosis and inhibiting cardiolipin synthesis |
| 04/13/2006 | US20060078558 Diagnosis, prognosis and treatment of pulmonary diseases |
| 04/13/2006 | US20060078555 Intraventricular hemorrhage thrombolysis |
| 04/13/2006 | US20060078549 Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as huntington's disease, by using coenzyme Q10 |
| 04/13/2006 | US20060078536 Polysaccharide-based polymer tissue adhesive for medical use |
| 04/13/2006 | US20060078534 Toxin binding compositions |
| 04/13/2006 | US20060078533 Method of prevention and treatment of aging and age-related disorders including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimer's disease and cancer |
| 04/13/2006 | US20060078532 Method of prevention and treatment of Atherosclerosis, Peripheral vascular disease, Coronary artery disease, aging and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease |
| 04/13/2006 | US20060078531 Method of prevention and treatment of atherosclerosis, peripheral vascular disease, coronary artery disease, and age-related disorders including osteoporosis, arthritis, type 2 diabetes, dementia and Alzheimer's disease |
| 04/13/2006 | US20060078530 Using high-density grapes to rejuvenate human skin |
| 04/13/2006 | US20060078505 Methods and kits for delivering drugs by nebulisation |
| 04/13/2006 | US20060078504 Sustanined-release pharmaceutical composition for lung administration |
| 04/13/2006 | US20060078499 Use of hedgehog agonist to treat depression |